Brighton Jones’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Brighton Jones's TAK Position: Q3 2026 in Review
Brighton Jones reduced its Takeda Pharmaceutical (TAK) stake by 4.8% in Q3 2026, selling an estimated $10.4K and leaving 11,663 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1241.
Brighton Jones first reported a position in TAK in Q1 2026 and has held it in 3 quarters since. 346 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Brighton Jones held 11,663 shares of Takeda Pharmaceutical worth $212K as of Q3 2026.
- Brighton Jones sold 587 Takeda Pharmaceutical shares in Q3 2026, an estimated $10.4K.
- Takeda Pharmaceutical made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1241 holding.
- Brighton Jones first reported a position in Takeda Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
- 346 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.